From Reuters.

Shares in Novo Nordisk rose as much as 5% at opening after the US FDA granted accelerated approval for Wegovy to treat metabolic dysfunction-associated steatohepatitis, or MASH.

#novonordisk #wegovyweightloss #wegovy #News #Reuters #Newsfeed

Read the story here: https://reut.rs/47FtT1U

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en